# Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers

> **NCT04231643** · EARLY_PHASE1 · TERMINATED · sponsor: **University of California, San Diego** · enrollment: 19 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Dronabinol
- **DRUG:** Epidiolex
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04231643
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-11-28
- **Final completion:** 2023-11-28
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Budgetary limitations prevented us from completing our planned sample size.
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04231643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04231643, "Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04231643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*